| 查看: 2440 | 回复: 23 | |||
[交流]
帮我分析分析是否中稿呢
|
|||
|
前段时间在IOP上投了篇文章，编辑回复如下： Thank you for your submission which will be considered for publication in *************. The reference number for your article is ********. Please quote this number in all future correspondence regarding this article. 还让填一份assignment of copyright ASSIGNMENT OF COPYRIGHT and DECLARATION OF RESPONSIBILITY 1. IOP Publishing Ltd ("the Publisher"  agrees to publishManuscript title: ********************* ("The Article" written by Names of all Authors: ****************************("the Named Authors" in the following journal: **********************("the Journal" 2. Transfer of Copyright Agreement 2.1 On acceptance for publication the undersigned author(s) (“Author”) of the Article assigns exclusively to IOP worldwide copyright in the Article for the full term and for all media and formats in all material published as part of the Article, which expression includes but is not limited to the text, abstract, tables, figures and graphs, but excludes any supplementary material. 2.2 If any of the Named Authors are Government employees, on acceptance for publication the Author shall grant IOP a royalty free exclusive licence for the full term of copyright for all media and formats to do in relation to the Article all acts restricted by copyright worldwide. 2.3 On acceptance for publication the Author shall grant IOP a royalty free non-exclusive licence for the full term of copyright for all media and formats to do in relation to any supplementary material deemed to be part of the Article all acts restricted by copyright worldwide. 3. Author Rights 3.1 IOP grants the Named Authors the rights specified in 3.2 and 3.3. All such rights must be exercised for non-commercial purposes, if possible should display citation information and IOP’s copyright notice, and for electronic use best efforts must be made to include a link to the on-line abstract in the Journal. Exercise of the rights in 3.3 additionally must not use the final published IOP format but the Named Author’s own format (which may include amendments made following peer review). 3.2 The rights are: 3.2.1 To make copies of the Article (all or part) for teaching purposes; 3.2.2 To include the Article (all or part) in a research thesis or dissertation; 3.2.3 To make oral presentation of the Article (all or part) and to include a summary and/or highlights of it in papers distributed at such presentations or in conference proceedings; and 3.2.4 All proprietary rights other than copyright. 3.3 The additional rights are to: 3.3.1 Use the Article (all or part) without modification in personal compilations or publications of a Named Author’s own works (provided not created by third party publisher); 3.3.2 Include the Article (all or part) on a Named Author’s own personal web site; 3.3.3 Include the Article (all or part) on web sites of the Institution (including its repository) where a Named Author worked when research for the Article was carried out; and 3.3.4 Include the Article (all or part) on third party web sites including e-print servers, but not on other publisher’s web sites. Signature In signing this Agreement the Author represents and warrants that the Article is the original work of the Named Authors, it has not been published previously in any form (other than as permitted under clause 3.2.2 which fact has been notified to IOP in writing), all Named Authors have participated sufficiently in the conception and writing of the Article, have received the final version of the Article, agree to its submission and take responsibility for it, and submission has been approved as necessary by the authorities at the establishment where the research was carried out. The Author warrants that he/she signs this Agreement as authorised agent for all Named Authors and has the full power to enter into this Agreement and to make the grants it contains, that the Article has not been and will not be submitted to another publisher prior to withdrawal or rejection, it does not infringe any third party rights, it contains nothing libellous or unlawful, all factual statements are to the best of the Author’s knowledge true or based on valid research conducted according to accepted norms, and all required permissions have been obtained in writing. All Named Authors assert their moral rights. Author’s signature………………………………………....………….Date…………………… Signature on behalf of Institution………………………………………Date……………………. |
回复此楼» 猜你喜欢
国自科面上基金字体
已经有6人回复
-
304求调剂
已经有3人回复
-
304求调剂
已经有6人回复
-
材料与化工一志愿南昌大学327求调剂推荐
已经有8人回复
-
0703 物理化学调剂
已经有5人回复
-
化学工程321分求调剂
已经有7人回复
-
0703化学调剂 290分有科研经历，论文在投
已经有7人回复
-
308求调剂
已经有3人回复
-
本人考085602 化学工程 专硕
已经有10人回复
-
焦虑
已经有9人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- 请大家帮我分析这个产物能不能过柱纯化呢？
已经有27人回复
- 麻烦大家帮我分析分析
已经有4人回复
- 各位大牛，帮我分析下出国公派读博，是不是离我越来越远了？
已经有27人回复
- 大家帮我分析下导师的答复，是不是没有什么希望，谢谢大家了！！！
已经有5人回复
- 这个导师是什么意思呢，大家帮我分析一下吧。
已经有46人回复
- 哪位高手帮我分析这张幅循环伏安曲线呢
已经有12人回复
- 北京和深圳，哪个好呢？请大家帮我分析下
已经有28人回复
- 大家帮我分析分析
已经有4人回复
- 【求助】大家来帮我分析下是不是要这么久
已经有14人回复
- 大家帮我分析一下有没有这种可能呢？谢谢
已经有13人回复
» 抢金币啦！回帖就可以得到:
-
崂山国家实验室博士后岗位招聘
+2/200
-
招收苏州国家实验室和苏州大学联合培养博士（2026年9月入学）
+1/82
-
浙江农林大学招收调剂
+1/82
-
博士后出站经验请教
+1/79
-
福建师范大学化学与材料学院杜克钊团队招生
+1/39
-
清华大学环境学院贺克斌院士团队招聘博士后
+1/33
-
【沈阳农业大学机械专硕调剂】
+2/30
-
纺织科学与工程、材料化工方向招收研究生
+1/28
-
新疆大学招收学硕调剂
+1/24
-
山东省植物基蛋白技术创新中心课题组联合培养硕士研究生招募启事
+1/13
-
南京医科大学-膜蛋白结构与功能课题组-招收2026级博士研究生
+1/12
-
福州大学国家级人才汤育欣教授课题组2026年招收”申请考核制“储能电池方向博士研究生
+1/9
-
教育部长江学者和创新团队发展计划”入选团队招收 材料，化学与化工博士研究生
+1/7
-
青岛科技大学可持续高分子团队 考研招生
+1/7
-
北京大学环境学院张子帅研究员招收科研助理
+1/7
-
【第三轮招生，31号截止】澳科大诚招2026秋全奖博士研究生（纳米医学/生物材料方向）
+1/6
-
重庆大学诚招2026年生物材料方向博士生
+1/4
-
澳大利亚科学院院士Prof.Gordon Wallace, University of Wollongong 全奖博士机会
+1/1
-
2026年浙江清华长三角研究院智慧能源中心招聘博士后-电气方向
+1/1
-
湖南大学2026博士招生-人工智能安全方向
+1/1
2楼2011-03-31 15:48:33
3楼2011-03-31 16:13:08
4楼2011-03-31 16:19:31
5楼2011-03-31 16:20:59
6楼2011-03-31 16:23:04
7楼2011-03-31 16:24:25
8楼2011-03-31 16:25:06
10楼2011-03-31 17:11:57
11楼2011-03-31 20:11:42
12楼2011-04-01 09:09:11
13楼2011-04-01 09:11:12
14楼2011-04-01 09:12:57
15楼2011-04-01 09:14:24
16楼2011-04-01 09:15:28
17楼2011-04-01 09:16:10
18楼2011-04-01 09:16:47
19楼2011-04-01 09:17:31
20楼2011-04-01 09:18:25
21楼2011-04-01 09:50:16
22楼2011-04-05 12:42:01
23楼2011-04-05 21:33:45
24楼2012-11-04 11:01:26
简单回复
2011-03-31 16:54
回复
